18 June 2024
18 June 2024
On the day it was due to be listed on Nasdaq, Telix shelved its initial public offering (IPO) plans citing “current market conditions”.
Keeping high-qualified, experienced clinical trial staff on board plays a crucial role in bringing new drugs to market. Dana Durkan of KPS Life discusses how to avoid fraudulent staff, navigate work from home dynamics, and keep hold of your most valued employees.
If Calquence receives FDA label expansion in MCL, it will achieve a unique position in the treatment-naive MCL market share.
Elion’s antifungal therapy SF001 targets aspergillosis, which can be caused by Aspergillus fumigatus, a pathogen of critical priority as per the WHO.
After a successful trial, the UK NHS has become the first to permanently adopt a subscription payment model for new antibiotics.
As Asda sets up a nationwide retail pharmacy in the UK, and US grocer pharmacies expand, scaling up this model will be the next frontier.
There are approximately twelve times more single-country adoptive cell therapy clinical trials being run in the APAC region than in Europe.
The US Food and Drug Administration (FDA) approved Biotest’s Yimmugo for the treatment of primary antibody deficiencies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
